Back to Search Start Over

In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection

Authors :
Juliana de Melo Batista dos Santos
Camila Pereira Soares
Fernanda Rodrigues Monteiro
Ralyria Mello
Jonatas Bussador do Amaral
Andressa Simões Aguiar
Mariana Pereira Soledade
Carolina Sucupira
Milena De Paulis
Juliana Bannwart Andrade
Flavia Jaqueline Almeida
Marco Aurélio Palazzi Sáfadi
Luciana Becker Mau
Jamile Menezes Brasil
Theresa Ramalho
Flávio V. Loures
Rodolfo Paula Vieira
Edison Luiz Durigon
Danielle Bruna Leal de Oliveira
André Luis Lacerda Bachi
Source :
Frontiers in Immunology, Vol 12 (2021), Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual), Universidade de São Paulo (USP), instacron:USP, Frontiers in Immunology
Publication Year :
2021
Publisher :
Frontiers Media S.A., 2021.

Abstract

Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin (SIgA). Therefore, in this study, we investigated the levels of specific-SIgA for SARS-CoV-2 and cytokines in the airways mucosa 37 patients who were suspected of COVID-19. According to the RT-PCR results, the patients were separated into three groups: negative for COVID-19 and other viruses (NEGS, n = 5); negative for COVID-19 but positive for the presence of other viruses (OTHERS, n = 5); and the positive for COVID-19 (COVID-19, n = 27). Higher specific-SIgA for SARS-CoV-2, IFN-β, and IFN-γ were found in the COVID-19 group than in the other groups. Increased IL-12p70 levels were observed in OTHERS group as compared to COVID-19 group. When the COVID-19 group was sub stratified according to the illness severity, significant differences and correlations were found for the same parameters described above comparing severe COVID-19 to the mild COVID-19 group and other non-COVID-19 groups. For the first time, significant differences are shown in the airway's mucosa immune responses in different groups of patients with or without respiratory SARS-CoV-2 infection.

Details

Language :
English
ISSN :
16643224
Volume :
12
Database :
OpenAIRE
Journal :
Frontiers in Immunology
Accession number :
edsair.doi.dedup.....765c4bd5e9ad34a7f66ec11a204444be
Full Text :
https://doi.org/10.3389/fimmu.2021.595343/full